Trial Profile
An Open Pilot Trial of BHV-4157 in Adult Subjects With Cerebellar Ataxia
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 16 Jun 2022
Price :
$35
*
At a glance
- Drugs Troriluzole (Primary)
- Indications Machado-Joseph Disease; Spinocerebellar ataxias
- Focus Therapeutic Use
- 10 Jun 2022 Planned End Date changed from 1 Sep 2021 to 1 Sep 2024.
- 10 Jun 2022 Planned primary completion date changed from 1 Apr 2021 to 1 Apr 2024.
- 28 Apr 2020 Planned End Date changed from 1 Jul 2020 to 1 Sep 2021.